Dual therapy with dox + Ab9 (right) to simultaneously suppress production of Aβ and remove plaques successfully reduces cortical plaque load (top) and oligomeric Aβ (bottom) when compared with vehicle-treated mice (left, top and bottom). Bars: (top) 2,000 µm; (bottom) 500 µm.